NextDocs Version 3.6 Supports DIA EDM
DIA 45th Annual Meeting, San Diego, CA-June 21, 2009-NextDocs Corporation today announced that Version 3.6 of its NextDocs Regulatory Document Management System will ship with pre-configured support and full validation documentation for the DIA Electronic Document Management (EDM) Reference Model. In addition, NextDocs will provide a complete set of fully-configured sample implementations including folder structures, document types and metadata that embody best practices and standard deployment scenarios. With these innovations, Version 3.6 will allow life sciences companies to deploy and validate Microsoft Office SharePoint Server-based document and quality management solutions very rapidly.
“Companies today do not have the time or resources available to start from scratch when implementing solutions for SOPs, regulatory documents or clinical documents, and it does not make sense to do so. Our customers are looking for guidance on implementing standard processes with industry best practices in the shortest amount of time and with the least involvement of resources,” said Matt Walz, Chief Technical Officer, NextDocs. “With pre-built, sample implementations and ready-to-use validation scripts, Version 3.6 compresses the implementation schedule and allows customers to quickly validate their document management environment.”
“Life sciences firms want to deploy compliance solutions faster and more easily,” said Michael Naimoli, U.S. life sciences industry solutions director, Microsoft Corp. “With incorporation of support for the DIA EDM Reference Model and a set of sample implementations, Version 3.6 of the NextDocs Regulatory Document Management System provides an out-of-the-box solution that can be implemented far more efficiently than traditional, legacy document management systems.”
“The DIA Reference Models represent a common approach to implementing Regulatory and Clinical content management solutions by standardizing system specifications and configurations,” said Chet Shemanski, Director of Product Management, NextDocs. “NextDocs is committed to helping our customers adopt the standard taxonomy provided by the reference model by providing pre-configured document inventories, metadata models, lifecycles, workflows and other artifacts that are in direct alignment with the Reference Model.”
The DIA EDM reference Model is an initiative being driven by a DIA committee driven by the belief that, according to its charter, “that the time has come for our industry to develop a taxonomy/metadata reference model for electronic document management. NextDocs is a strong supporter of the initiative, because it means NextDocs customers can leverage a standard set of structures rather than developing their own information structures.”
NextDocs Version 3.6 is scheduled to ship in summer 2009.
About NextDocs
NextDocs is a leading provider of Microsoft Office SharePoint Server-based document and quality management solutions for the life sciences companies that fully support compliance with 21 CFR Part 11. Our mission is to deliver cost effective, easy to use document management software which provides immediate productivity increases for companies operating in regulatory environments. NextDocs customers include pharmaceutical companies, bio-techs, medical device companies and CROs. For more information please visit http://www.nextdocs.com or email sales@nextdocs.com.
Visit NextDocs at DIA in booth # 1033.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
